Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.2 USD | +3.45% | +4.80% | -79.49% |
May. 14 | Maxim Downgrades Augmedix to Hold From Buy | MT |
May. 14 | B. Riley Adjusts Price Target on Augmedix to $3 From $5.50, Keeps Buy Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-79.49% | 58.49M | |
+16.14% | 71.02B | |
+6.93% | 17.38B | |
+12.92% | 13.88B | |
+18.85% | 13.49B | |
+15.25% | 10.07B | |
-18.97% | 7.08B | |
-2.02% | 6.12B | |
+3.92% | 5.3B | |
+0.94% | 5.06B |
- Stock Market
- Equities
- AUGX Stock
- News Augmedix, Inc.
- B. Riley Resumes Augmedix at Buy with $6.50 PT, Says Recent Capital Raise/Uplisting to Nasdaq Supports Growth Strategy Execution